TimeWaver
The TimeWaver system operates on the principle of utilizing precise frequencies and low-intensity currents to enhance cellular health by restoring the correct potential of cell membranes. This approach was bolstered by the 1991 Nobel Prize-winning work of Dr. Bert Sakmann and Dr. Erwin Neher, who studied the permeability of microcurrents in human cell membranes, further solidifying the scientific foundation for the use of microcurrents in medical science. B. Nordenstrom's research in 1983 also demonstrated that low voltage currents could return cells with lost potential to a normal physiological state. The TimeWaver system aims to rebalance electrolytes and reposition ions within and outside cells, thereby restoring cell membrane potential. It is recognized as a Class IIa medical device under European Directive 93/42/EWG, indicating its certified status across Europe, developed through a collaboration between Nuno Nina and TimeWaver.
The TimeWaver technology extends its application beyond clinical settings with the TimeWaver Home version, allowing users to undergo treatment at their convenience. This system is based on the premise that everything at the atomic and subatomic level is in perpetual motion, vibrating at specific frequencies. These frequencies are crucial for cellular communication and overall bodily harmony. Discrepancies in an organ's frequency can disrupt this harmony. Dr. Nuno Nina leveraged his understanding of frequencies to develop "Gold Frequencies," aimed at restoring the membrane potential of cells. TimeWaver Frequency therapy, thus, has broad applications ranging from pain management (including headaches and osteo-articular pain) and mental health issues (such as depression and anxiety) to oncological and degenerative diseases, serving both therapeutic and preventive purposes for individuals looking to maintain or recover health.